搜索临床试验以:序列 2 - 治疗 C:控释普瑞巴林
总计129个结果
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
GlaxoSmithKline完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
AstraZenecaAcerta Pharma, LLC完全的
-
Shandong Branden Med.Device Co.,LtdFudan University未知
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Lizora LLCSheng'ai Traditional Chinese Medicine Hospital完全的
-
Foundation for Innovative New Diagnostics, SwitzerlandInstitute of Tropical Medicine, Belgium完全的
-
US Department of Veterans AffairsAgency for Healthcare Research and Quality (AHRQ)完全的
-
University of AthensNaval Hospital, Athens; General Hospital of Nikaia "Saint Panteleimon"招聘中
-
GlaxoSmithKline完全的
-
Northwestern UniversityNational Cancer Institute (NCI); Pfizer终止IV 期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | HER2/Neu阳性 | 孕激素受体阴性 | 乳腺癌脑转移美国
-
National Cancer Institute (NCI)Gynecologic Oncology Group完全的复发性子宫体癌 | 子宫内膜腺癌 | III 期子宫体癌 AJCC v7 | IV 期子宫体癌 AJCC v7 | ERBB2基因扩增美国
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbH终止